CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
encainide +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000504
NCT00000504Phase 2Completed
CompareCT.gov

Cardiac Arrhythmia Pilot Study (CAPS)

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Apr 27, 2012

In Brief

A Phase 2 clinical trial evaluating encainide, moricizine, and 2 other interventions for Arrhythmia and 3 related conditions. Completed.

Detailed Summary

To compare the effectiveness of various drugs and drug combinations in suppressing complex ventricular arrhythmias, and to evaluate their safety.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArrhythmia, Cardiovascular Diseases, Heart Diseases, Ventricular Arrhythmia
Countries--
Collaborators--

Timeline

Phase 2CompletedFinished
1982198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartSep 1, 1982
Study CompletionSep 1, 1985
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

encainidedrug

moricizinedrug

flecainidedrug

imipraminedrug